The formation of circulating platelet-leukocyte complexes has been observed in a variety of conditions and may be pathophysiologically significant. Platelet-leukocyte interactions in fact facilitate metabolic cooperation and mutual activation, which may be of relevance in many biological processes including inflammation, atherogenesis and hemostasis. During hemodialysis procedure, the series of reactions that can occur upon blood contact with the foreign membrane surface may involve a variety of changes affecting almost every cellular and plasmatic component of the blood. This article reviews the evidence for abnormal interactions between circulating platelets and leukocytes in uremic patients undergoing maintenance hemodialysis and the pathophysiologic implications which may stem from such interactions.
HakimR.M.1993. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int. 44:484.
2.
OpatrnyK.Jr, 2003. Clinical importance of biocompatibility and its effects on hemodialysis treatment. Nephrol. Dial. Transplant.18(S):41.
3.
CraddockP.R.FerhJ.BrighamK.L.KronenbergR.S.JacobsH.S., 1977. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N. Engl. J. Med.296:769.
4.
MahioutA.JorresA.MeinholdH.KesselM., 1986. Prostaglandin production and extracorporeal complement activation by dialyzer membranes. Tran. Am. Soc. Artif. Intern. Organs32:88.
5.
MahioutA.JorresA.SchultzeG.MeinholdH.KesselM., 1989. Eicosanoid release as laboratory indicator of biocompatibility. Artif. Organs13:251.
6.
PereiraB.J.G.DinarelloC.A., 1994. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol. Dial. Transplant.9(S):60.
BonominiM.StuardS.AlbertazziA., 1997. Cell-associated adhesion molecules in hemodialysis. Int. J. Immunopathol. Pharmacol.10:37.
9.
DhodtA.VanholderR.LameireN., 1998. Hemodialysis-related bioincompatibility and adhesion molecules. Int. J. Artif. Organs21:501.
10.
BlumensteinM.Ziegler-HeitbrockH.W.L.SchillerB.SchmidtB.WardR.A.GurlandH.J., 1990. Differential activation of monocytes in haemodialysis patients exposed to different types of membranes. Scand. J. Immunol.31:183.
11.
HimmelfarbJ.AultK.A.HolbrookD.LeeberD.A.HakimR.M., 1993. Intradialytic granulocyte reactive oxygen species production: A prospective, crossover trial. J. Am. Soc. Nephrol.4:178.
12.
RinderH.M.BonanJ.L.RinderC.S.AultK.A.SmithB.R., 1991. Dynamics of leukocyte platelet adhesion in whole blood. Blood78:1730.
13.
de GaetanoG.CerlettiC.EvangelistaV., 1999. Recent advances in platelet-polymorphonuclear leukocyte interactions. Haemostasis29:41.
14.
FaintR.W.1992. Platelet-neutrophil interactions: Their significance. Blood Rev. 6:83.
15.
BazzoniG.DecanaE.Del MaschioA., 1991. Platelet neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica76:491.
16.
McEverR.P.2000. Adhesive interactions of leukocytes, platelets and the vessel wall during hemostasis and inflammation. Thromb. Haemost.86:746.
17.
FreedmanJ.E.LoscalzoJ., 2002. Plateletmonocyte aggregates: Bridging thrombosis and inflammation. Circulation105:2130.
18.
BonominiM.SirolliV.StuardS.SettefratiN., 1999. Interactions between platelets and leukocytes during hemodialysis. Artif. Organs23:23.
19.
LarsenE.CeliA.GilbertG.E.FurieB.C.ErbanJ.K.BonfantiR.WagnerD.D.FurieB., 1989. PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell59:305.
20.
RinderH.M.BonanJ.L.RinderC.S.AultK.A.SmithB.R., 1991. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood78:1760.
21.
OttI.NeumannF.J.GawazM.SchmittM.SchomigA., 1996. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation94:1239.
22.
FaradayN.BraunsteinJ.B.HeldmanA.W.BoltonE.D.ChilesK.A.GerstenblithG.SchulmanS.P., 2004. Prospective evaluation of the relationship between platelet-leukocyte conjugate formation and recurrent myocardial ischemia in patients with acute coronary syndromes. Platelets15:9.
23.
MickelsonJ.K.LakkisN.M.Villarreal-LevyG.HughesB.J.SmithS.W., 1996. Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease?J. Am. Coll. Cardiol.28:345.
24.
NeumannF.J.OttI.GawazM.PuchnerG.SchomigA., 1996. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J. Am. Coll. Cardiol.27:819.
25.
RusswurmS.VickersJ.Meier-HellmannA.SpangenbergP.BredleD.ReinhartK.LoscheW., 2002. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Shock17:263.
26.
KirschenbaumL.A.AdlerD.AstizM.E.BaruaR.S.SahaD.RackowE.C., 2002. Mechanisms of platelet-neutrophil interactions and effects on cell filtration in septic shock. Shock17:508.
PetersM.J.HeydermanR.S.FaustS.DixonG.L.InwaldD.P.KleinN.J., 2003. Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet-neutrophil complexes. J. Leukoc. Biol.73:722.
29.
TurtteH.A.Davis-GormanG.GoldmanS.CopelandJ.G.McDonaghP.E., 2003. Platelet-neutrophil conjugate formation is increased in diabetic women with cardiovascular disease. Cardiovasc. Diabetol.4:2.
30.
BradyH.R.PapayianniA.SerhanC.N., 1994. Leukocyte adhesion promotes biosynthesis of lipoxygenase products by transcellular routes. Kidney Int. 45(S):90.
31.
EvangelistaV.ManariniS.SideriR.RotondoS.MartelliN.PiccoliA.TotaniL.PiccardoniP.VestweberD.de GaetanoG., 1999. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: Role of PSGL-1 as a signaling molecule. Blood93:876.
32.
PetersM.J.DixonG.KotowiczK.T.HatchD.J.HeydermanR.S.KleinN.J., 1999. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br. J. of Haemat. 106:391.
33.
NashG.B.1994. Adhesion between neutrophils and platelets: A modulator of thrombotic and inflammatory events?Thromb. Res.74(S):3.
34.
EvangelistaV.PiccardoniP.WhiteJ.G.de GaetanoG.CerlettiC., 1993. Cathepsin-G dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: Role of P-selectin-mediated cell-cell adhesion. Blood81:2947.
35.
WareJ.A.HeistadD.D., 1993. Platelet endothelium interactions. N. Engl. J. Med.328:628.
36.
GawazM.P.MujaisS.K.SchmidtB.GurlandH.J., 1994. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 46:489.
37.
KawabataK.NakaiS.MiwaM.SugiuraT.OtsukaY.ShinzatoT.HikiY.TomimatsuI.UshidaY.HasonoF.MaedaK., 2002. Platelet GPIIb/IIIa is activated and platelet-leukocyte coaggregates formed in vivo during hemodialysis. Nephron90:391.
38.
StuardS.CarrenoM.P.PoignetJ.L.AlbertazziA.Haeffner-CavaillonN., 1995. A major role for CD62P/CD15s interaction in leukocyte margination during hemodialysis. Kidney Int. 48:93.
39.
StuardS.BonominiM.SettefratiN.AlbertazziA., 1998. Platelet-neutrophil interactions during hemodialysis: A proposed biocompatibility approach. Int. J. Artif. Organs.21:75.
40.
BonominiM.SirolliV.SettefratiN.StuardS.TropeaF.Di LiberateL.TettaC.AlbertazziA., 1999. Surface antigen expression and platelet neutrophil interactions in haemodialysis. Blood Purif. 17:107.
41.
SirolliV.Di StanteS.StuardS.Di LiberateL.AmorosoL.CappelliP.BonominiM., 2000. Biocompatibility and functional performance of a polyethylene glicol acid-grafted cellulosic membrane for hemodialysis. Int. J. Artif. Organs23:356.
42.
SirolliV.BalloneE.AmorosoL.Di LiberateL.Di MascioR.CappelliP.AlbertazziA.BonominiM., 1999. Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: Effects of different synthetic membranes. Int. J. Artif. Organs22:536.
43.
SirolliV.BalloneE.Di StanteS.AmorosoL.BonominiM., 2002. Cell activation and cellular-cellular interactions during hemodialysis: Effect of dialyzer membrane. Int. J. Artif. Organs25:529.
44.
BonominiM.Di StanteS.SirolliV., 2003. Biocompatibility of DIAPES. Contrib. Nephrol.138:117.
45.
CarrenoM.P.StuardS.BonominiM.SettefratiN.TettaC.AlbertazziA.Haeffner-CavaillonN., 1996. Cell-associated adhesion molecules as early markers of bioincompatibility. Nephrol. Dial. Transplant.11:2248.
46.
HimmelfarbJ.ZaouiP.HakimR., 1992. Modulation of granulocyte LAM 1 and MAC1 during dialysis a prospective, randomized controlled trial. Kidney Int. 41:388.
47.
NagataK.TsujiT.TodorokiN.KatagiriY.TanoueK.YamazakiH.HanaiN.IrimuraT., 1993. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin. J. Immunol.151:3267.
48.
SchomigM.EisenhardtA.RitzE., 2000. The microinflammatory state of uremia. Blood Purif. 8:327.
49.
BonominiM.StuardS.CarrenoM.P.SettefratiN.SantarelliP.Haeffner-CavaillonN.AlbertazziA., 1997. Neutrophil reactive oxygen species production during hemodialysis: Role of activated platelet adhesion to neutrophils through P-selectin. Nephron75:402.
50.
RosenkranzA.R.TempiE.TraindlO.HeinzlH.ZlabingerG.J., 1994. Reactive oxygen product formation by human neutrophils as an early marker for biocompatibility of dialysis membrane. Clin. Exp. Immunol.98:300.
51.
Cappelliere-BlandinC.DelaveauT.Descamps-LatschaB., 1991. Structural modifications of human beta 2-microglobulin treated with oxygen-derived radicals. Biochem. J.277:175.
52.
WeissS.J.YoungJ.LoBuglioA.F.SlivkaA.NimerN.F., 1981. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J. Clin. Invest.68:714.
53.
AgerA.GordonJ.L., 1984. Differential effects of hydrogen peroxide on indices of endothelial cell function. J. Exp. Med.159:592.
54.
SchulmanG.FagoA.GungA.BadrK.HakimR., 1991. Complement activation retards resolution of ischemic renal failure in the rat. Kidney Int. 40:1069.
55.
HolliwellB.1993. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis23(S):118.
56.
YagiK.1986. A biochemical approach to atherogenesis. Trends Biochem. Sci.11:18.
57.
LinderA.CharnaB.SherrandD.J.ScribnerB.H., 1974. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N. Engl. J. Med.290:697.
58.
AmannK.GrossM.L.RitzE., 2004. Pathophysiology underlying accelerated atherogenesis in renal disease: Closing in on the target. J. Am. Soc. Nephrol.15:1664.
59.
FoleyR.N.ParfreyP.S.SarnakM.J., 1998. Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol.9(S):S16.
60.
HerzogC.A.MaJ.Z.CollinsA.J., 1998. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N. Engl. J. Med.339:799.
61.
GalleJ.WannerC., 1997. Oxidative stress and vascular injury - relevant for atherogenesis in uraemic patients?Nephrol. Dial. Transplant.12:2480.
62.
NeumannF.J.ZohlnhoferD.FakhouryL.OttI.GawazM.SchomigA., 1999. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J. Am. Coll. Cardiol.34:1420.
63.
CeliA.PellegriniG.LorenzetR.De BlasiA.ReadyN.FurieB.C.FurieB., 1994. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. U.S.A.91:8767.
64.
NeumannF.J.MarxN.GawazM.BrandK.OttI.RokittaC.SticherlingC.MeinlC.MayA.SchomigA., 1997. Induction of cytokine expression in leukocytes by binding of thrombinstimulated platelets. Circulation95:2387.
65.
WeyrichA.S.McIntyreT.M.McEverR.P.PrescottS.M.ZimmermanG.A., 1995. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-α secretion. Signal integration and NF-kappaB translocation. J. Clin. Invest.95:2297.
66.
WeyrichA.S.ElstadM.R.McEverR.P.McIntyreT.M.MooreK.L.MorrisseyJ.H.PrescottS.M.ZimmermanG.A., 1996. Activated platelets signal chemokine synthesis by human monocytes. J. Clin. Invest.97:1525.
67.
HuoY.LeyF.K., 2004. Role of platelets in the development of atherosclerosis. Trends Cardiovasc. Med.14:18.
68.
HuoY.SchoberA.ForlowS.B.SmithD.F.HymanM.C.JungS.LittmanD.R.WeberC.LeyK., 2003. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat. Med.9:61.
69.
Van der WalA.C.BeckerA.E., 1999. Atherosclerotic plaque rupture - basis of plaque stability and instability. Cardiovasc. Res.41:344.
70.
FurmanM.I.BarnardM. R.KruegerL. A.FoxM. L.ShilaleE. A.LessardD. M.MarcheseP.FrelingerA. L.3rdGoldbergR. J., 2001. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J. Am. Coll. Cardiology38:1002.
71.
FurmanM.I.BenoitS.E.BarnardM.R.ValeriC.R.BorboneM.I.BeckerR.C.HechtmanH.B.MichelsonA.D., 1998. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J. Am. Coll. Cardiology31:352.
72.
SarmaJ.LaanC.A.AlamS.JhaA.FoxK.A.DransfieldI., 2002. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation105:2166.
73.
HardingS.A.SommerfieldA.J.SarmaJ.TwomeyP.J.NewbyD.E.FrierB.M.FoxK.A., 2004. Increased CD40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis176(2):321.
74.
VillmowT.Kemkes-MatthesB.MatzdorffA.C., 2002. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb. Res.108(2):139.
75.
WunT.CordobaM.RangaswamiA.CheungA.W.PaglieroniT., 2002. Activated monocytes and platelet-monocyte aggregates in patients with sickle cell disease. Clin. Lab. Haematol.24(2):81.
76.
HardingS.A.SarmaJ.JosephsD.H.CrudenN.L.DinJ.N.TwomeyP.J.FoxK.A.A.NewbyD.E., 2004. Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers. Circulation109:1926.
77.
MichelsonA.D.BarnardM.R.KruegerL.A.ValeriC.R.FurmanM.I., 2001. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation104:1533.
78.
RayM.J.WaltersD.L.BettJ.N.CameronJ.WoodP.AroneyC.N., 2005. Platelet-monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by abciximab. Int. J. Cardiol.101(2):249.
79.
AshmanN.MaceyM.G.FanS.L.AzamU.YaqoobM.M., 2003. Increased platelet-monocyte aggregates and cardiovascular disease in end stage renal failure patients. Nephrol. Dial. Transplant.18:2088.
80.
HennV.SlupskyJ.R.GrafeM.AnagnostopoulosI.ForsterR.Muller-BerghausG.KroczekR.A., 1998. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature391:591.
81.
LindmarkE.TennoT.SiegbahnA., 2000. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler. Thromb. Vasc. Biol.20:2322.
82.
SchonbeckU.LibbyP., 2001. CD40 signaling and plaque instability. Circ. Res.89:1092.
